Article
Cystic fibrosis risk variants confer protection against inflammatory bowel disease.
Cell genomics - 11 Feb 2026
Yu Mingrui, Zhang Qian, Yuan Kai, Sazonovs Aleksejs, Stevens Christine R, Fachal Laura, Lamb Christopher A, Anderson Carl A, Daly Mark J, Huang Hailiang
Abstract excerpt
Genetic mutations that yield a defective cystic fibrosis (CF) transmembrane regulator (CFTR) protein cause CF, a life-limiting autosomal-recessive Mendelian disorder. A protective role of CFTR loss-of-function mutations in inflammatory bowel disease (IBD) has been suggested, but its evidence has been inconclusive and contradictory. Here, leveraging a large IBD exome sequencing dataset comprising 38,558 cases and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
